A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells

BACKGROUND: Cancer-specific adoptive T cell therapy has achieved successful milestones in multiple clinical treatments. However, the commercial production of cancer-specific T cells is often hampered by laborious cell culture procedures, the concern of retrovirus-based gene transfection, or insuffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Jou, Chen, Michael, Cheng, Tian-Lu, Tsai, Yi-Shan, Wang, Chang-Hung, Chen, Che-Yi, Wu, Tung-Yun, Tzou, Shey-Cherng, Wang, Kai-Hung, Cheng, Jing-Jy, Kao, An-Pei, Lin, Shyr-Yi, Chuang, Kuo-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230823/
https://www.ncbi.nlm.nih.gov/pubmed/37259079
http://dx.doi.org/10.1186/s12929-023-00929-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230823/
https://www.ncbi.nlm.nih.gov/pubmed/37259079
http://dx.doi.org/10.1186/s12929-023-00929-z

Ejemplares similares